Acceleron Pharma (United States)
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Acceleron Pharma (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
36%
Total
Publications
367
Total Open
Publications
132
Total
Citations
16K
Open Access
Percentage
36%
Total
Publications
367
Total Open
Publications
132
Total
Citations
16K
Breakdown
Publisher Open
7%
Both
18%
Other Platform Open
9%
Closed
66%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
38
Hybrid 20%
18
No Guarantees 38%
34
Other Platform Open
Domain 69%
68
Other Internet 27%
27
Institution 25%
25
Preprint 2%
2
Public 1%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 69 |
DOI | Other Internet | 27 |
Europe PMC | Domain | 5 |
Royal Netherlands Academy of Arts and Sciences | Institution | 4 |
Harvard University | Institution | 4 |
University of Modena and Reggio Emilia | Institution | 3 |
University of Milan | Institution | 3 |
University of Florence | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
Washington University in St. Louis | Institution | 1 |